Upgrade to SI Premium - Free Trial

Boston Scientific (BSX) Reports VICI VENOUS STENT System Demonstrates Positive Clinical Outcomes in Patients with Deep Venous Blockages

January 22, 2019 6:13 AM
Boston Scientific (NYSE: BSX) announced positive 12-month data demonstrating that patients who were treated with the VICI VENOUS STENT® System ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles